Table 2. Regression analysis between various clinical factors and the soluble epidermal growth factor receptor in T2DM group.
Variable | Univariate regression | Multivariate regression | |||||
---|---|---|---|---|---|---|---|
R | R2 | β±SE | P value | Partial R2 | β±SE | P value | |
Male sex | 0.159 | 0.025 | −5.112±3.166 | 0.110 | |||
Age | 0.276 | 0.076 | −0.358±0.124 | 0.005 | 0.001 | −0.053±0.161 | 0.744 |
Height | 0.211 | 0.044 | 0.376±0.175 | 0.034 | 0.001 | −0.081±0.226 | 0.723 |
Body weight | 0.125 | 0.016 | 0.148±0.117 | 0.207 | |||
Waist circumference | 0.242 | 0.059 | −0.337±0.172 | 0.054 | |||
Body mass index | 0.002 | 0.000 | −0.007±0.394 | 0.986 | |||
Smoking status | |||||||
Current smoker | 0.163 | 0.026 | 6.153±3.712 | 0.101 | |||
Former smoker | 0.125 | 0.016 | 1.895±1.491 | 0.207 | |||
Never | 0.229 | 0.053 | −3.716±1.570 | 0.020 | 0.060 | −3.988±1.425 | 0.006 |
Hypertension | 0.108 | 0.012 | −3.633±3.339 | 0.279 | |||
Dyslipidemia | 0.129 | 0.017 | −5.199±3.988 | 0.195 | |||
Coronary artery disease | 0.110 | 0.012 | −7.532±6.749 | 0.267 | |||
Cerebrovascular disease | 0.075 | 0.006 | 5.140±6.772 | 0.450 | |||
Systolic BP | 0.062 | 0.004 | −0.056±0.089 | 0.535 | |||
Diastolic BP | 0.038 | 0.001 | 0.060±0.157 | 0.705 | |||
Hemoglobin | 0.162 | 0.026 | 1.602±1.002 | 0.113 | |||
HbA1c | 0.470 | 0.221 | 3.440±0.646 | <0.001 | 0.166 | 3.143±0.675 | <0.001 |
Fasting glucose | 0.407 | 0.166 | 0.110±0.024 | <0.001 | 0.016 | 0.074±0.052 | 0.155 |
PP2 glucose | 0.469 | 0.220 | 0.075±0.015 | <0.001 | 0.001 | −0.002±0.029 | 0.951 |
Fasting C-peptide | 0.160 | 0.026 | −6.801±4.258 | 0.113 | |||
PP2 C-peptide | 0.450 | 0.202 | −4.770±1.034 | <0.001 | 0.001 | 0.685±2.491 | 0.784 |
Fasting insulin | 0.256 | 0.066 | −0.620±0.238 | 0.011 | 0.037 | −0.785±0.359 | 0.032 |
PP2 insulin | 0.410 | 0.168 | −0.142±0.034 | <0.001 | 0.005 | −0.080±0.092 | 0.388 |
HOMA-IR | 0.056 | 0.003 | −0.310±0.558 | 0.579 | |||
HOMA-β | 0.296 | 0.087 | −0.102±0.033 | 0.003 | 0.028 | 0.141±0.075 | 0.065 |
Apolipoprotein A | 0.072 | 0.005 | −0.044±0.084 | 0.603 | |||
Apolipoprotein B | 0.226 | 0.051 | 0.131±0.077 | 0.094 | |||
Triglyceride | 0.198 | 0.039 | 0.013±0.006 | 0.045 | 0.004 | −0.007±0.010 | 0.497 |
Total cholesterol | 0.366 | 0.134 | 0.113±0.029 | <0.001 | 0.081 | 0.107±0.033 | 0.002 |
Serum creatinine | 0.274 | 0.075 | 4.337±1.517 | 0.005 | 0.014 | 1.976±1.451 | 0.178 |
Estimated GFR | 0.012 | 0.001 | −0.003±0.027 | 0.907 | |||
HDL-C | 0.064 | 0.004 | −0.075±0.118 | 0.527 | |||
LDL-C | 0.272 | 0.074 | 0.092±0.033 | 0.006 | 0.001 | −0.011±0.106 | 0.921 |
T2DM, type 2 diabetes mellitus; SE, standard error; BP, blood pressure; HbA1c, glycosylated hemoglobin; PP2, 2-hour postprandial; HOMA-IR, homeostatic model assessment of insulin resistance; HOMA-β, homeostatic model assessment of β-cell function; GFR, glomerular filtration rate; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol.